The cost to develop new drugs and vaccines is growing and the success rate may be slowing. Likelihood of approval for new FDA Phase I
Tag: Bristol Myers Squibb
“Patents Enable Investment” says Henry Hadad on Season Premiere of Understanding IP Matters
When it comes to IP rights, confusion reigns. Some people believe weaker IP systems that encourage uncertain patents result in lower drug prices and more
ipcloseup.com 